ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.
- DOI
- 10.1002/1878-0261.70254
- Published
- 2026 Aug
- Container
- Molecular oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1878-0261.70254,
title = {ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.},
author = {Stergiopoulou D and Markou A and Nicolo E and Serafini MS and Zhang Q and Zhang Y and Gerratana L and Davis AA and Liu H and Gradishar WJ and Reduzzi C and Cristofanilli M and Lianidou E},
year = {2026},
journal = {Molecular oncology},
doi = {10.1002/1878-0261.70254},
url = {https://doi.org/10.1002/1878-0261.70254}
}RIS
TY - JOUR TI - ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study. AU - Stergiopoulou D AU - Markou A AU - Nicolo E AU - Serafini MS AU - Zhang Q AU - Zhang Y AU - Gerratana L AU - Davis AA AU - Liu H AU - Gradishar WJ AU - Reduzzi C AU - Cristofanilli M AU - Lianidou E PY - 2026 JO - Molecular oncology DO - 10.1002/1878-0261.70254 UR - https://doi.org/10.1002/1878-0261.70254 ER -
APA
D, S., A, M., E, N., MS, S., Q, Z., Y, Z., L, G., AA, D., H, L., WJ, G., C, R., M, C., & E, L. (2026). ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.. Molecular oncology. https://doi.org/10.1002/1878-0261.70254
Source records
- pubmed · retrieved 2026-09-26T13:09:43.658Z
- europe-pmc · retrieved 2026-09-26T13:09:43.666Z
- doaj · retrieved 2026-09-26T13:09:43.627Z